Right Ventricular Mechanical Dyssynchrony Reflects Hemodynamic Load in Pre‐Capillary Pulmonary Hypertension Authors: Sachiyo Igata, Nobuhiro Tahara, Atsuko Tahara, Akihiro Honda, Tadahiro Kugai, Yoshiko Eto, Shoko Maeda‐Ogata, Yoshihiro Fukumoto Published: 2026 ABSTRACT ABSTRACTRight ventricular (RV) mechanical dyssynchrony represents a maladaptive response to increased afterload in pulmonary hypertension (PH). However, its hemodynamic and biochemical determinants remain unclear. This study aimed to identify the clinical, hemodynamic, and biochemical correlates of RV dyssynchrony in patients with pre‐capillary PH. Thirty patients with pre‐capillary PH (83% female; age 56 ± 19 years), all without intraventricular conduction delay (QRS < 120 ms), underwent right heart catheterization, cardiac magnetic resonance imaging, and two‐dimensional speckle‐tracking echocardiography. RV dyssynchrony was quantified using the coefficient of variation of time‐to‐peak systolic strain in four mid‐basal RV segments (RV‐CV4) adjusted for heart rate. Mean pulmonary artery pressure (mPAP), pulmonary vascular resistance (PVR), and RV‐CV4 averaged 34.1 ± 11.2 mmHg, 522.3 (interquartile range, 289.4–692.6) dyn·s·cm−5, and 0.134 ± 0.083, respectively, in a cohort with predominantly mild‐to‐moderate RV systolic dysfunction. RV dyssynchrony correlated significantly with mPAP (β = 0.509) PVR (β = 0.507), and RV‐pulmonary artery coupling (β = −0.406) (all p < 0.05). In multivariate analysis, mPAP remained the sole independent predictor of RV dyssynchrony (β = 0.509, 95% CI 0.001–0.006, p = 0.004), accounting for 26% of its variance. Neither RV end‐diastolic volume nor RV ejection fraction were independently associated with dyssynchrony. RV mechanical dyssynchrony reflects hemodynamic afterload, particularly elevated mPAP, rather than structural remodeling. Notably, dyssynchrony was evident even in mild‐to‐moderate RV dysfunction, indicating an early manifestation of pressure‐induced impairment. RV‐CV4 may serve as a noninvasive marker of pulmonary vascular load and highlight the importance of afterload reduction in optimizing RV mechanical coordination. Accordingly, RV dyssynchrony assessment may provide a practical echocardiographic surrogate for invasive hemodynamic evaluation in clinical practice. Background Pulmonary hypertension (PH) is characterized by a progressive elevation of pulmonary vascular resistance (PVR), ultimately leading to right ventricular (RV) failure and premature death [1, 2]. The RV adapts to chronic pressure overload through complex structural and functional remodeling, ranging from compensatory concentric hypertrophy with preserved systolic performance to maladaptive dilatation and failure [3, 4]. These divergent remodeling phenotypes carry distinct prognostic implications, highlighting the need for a detailed characterization of RV mechanics beyond conventional volumetric indices. Echocardiography remains central to noninvasive RV assessment. Standard indices such as tricuspid annular plane systolic excursion (TAPSE), fractional area change (FAC), and tissue Doppler‐derived systolic velocity (S') predominantly reflect longitudinal shortening and global systolic performance, but may overlook regional heterogeneity of RV contraction [5, 6, 7, 8, 9]. Two‐dimensional speckle‐tracking echocardiography (2D‐STE) enables angle‐independent quantification of myocardial deformation, providing novel mechanistic insights into RV mechanics including regional strain distribution and mechanical dyssynchrony [10, 11, 12, 13, 14]. Right ventricular mechanical dyssynchrony (RVD), defined as the temporal dispersion of regional systolic shortening, has emerged as an indicator of mechanical inefficiency and early maladaptation in PH [13, 15]. RVD arises from multiple mechanisms: heterogeneous wall stress under pressure overload, septal shift with altered interventricular coupling, regional dilatation, and subclinical metabolic abnormalities [16, 17]. Growing evidence links RVD to disease severity, right atrial pressure, and clinical outcomes in PH [18, 19, 20]. However, the upstream determinants of RVD, whether primarily driven by hemodynamic load, structural remodeling, or metabolic stress, remain insufficiently defined. Circulating biomarkers provide complementary insights into RV pathophysiology. N‐terminal pro‐brain natriuretic peptide (NT‐pro‐BNP) reflects myocardial wall stress and volume overload [21, 22], whereas serum uric acid, the final product of purine metabolism, reflects oxidative and metabolic stress during hypoxia [23, 24, 25]. Elevated uric acid levels are associated with adverse outcomes in pulmonary arterial hypertension (PAH), however, their relationship to mechanical abnormalities of RV contraction, particularly dyssynchrony, has not been systematically explored. We hypothesized that RV mechanical dyssynchrony primarily reflects hemodynamic afterload in pre‐capillary PH. This study aimed to (1) quantify RV mechanical dyssynchrony using 2D‐STE, (2) identify its hemodynamic and structural determinants using comprehensive multimodality assessment including right heart catheterization (RHC) and cardiac magnetic resonance imaging (CMR), and (3) assess its association with circulating biomarkers. Importantly, this study addresses three unresolved questions in the current literature: whether RV dyssynchrony is primarily driven by hemodynamic load in the absence of electrical conduction delay, whether it is dissociated from conventional indices of structural remodeling, and whether metabolic stress contributes to mechanical discoordination. Clarifying these relationships may enhance understanding of RV maladaptation and support noninvasive risk stratification in PH. Methods Study Design and Population This single‐center, retrospective observational study included 30 consecutive patients diagnosed with pre‐capillary PH by RHC at Kurume University Hospital. Pre‐capillary PH was defined according to current guidelines as mean pulmonary artery pressure (mPAP) ≥ 20 mmHg, pulmonary artery wedge pressure (PAWP) ≤ 15 mmHg, and PVR > 2 Wood units at rest [26]. Eligible participants were adults (≥ 18 years) with confirmed pre‐capillary PH who had adequate echocardiographic image quality for speckle‐tracking analysis and complete clinical and laboratory data. Exclusion criteria included QRS duration ≥ 120 ms, atrial fibrillation with heart rate > 100 or < 60 bpm, significant left‐sided valvular heart disease, prior cardiac surgery or pacemaker implantation, or insufficient echocardiographic image quality. All participants underwent comprehensive evaluation including echocardiography, CMR, 6 min walk test, and blood sampling within 2 weeks of RHC. Clinical data, medications, and comorbidities were obtained from electronic medical records. The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Kurume University (approval number: 13281). Written informed consent was obtained from all participants. Right Heart Catheterization RHC was performed using a 7 F Swan‐Ganz catheter (Baxter Healthcare, Santa Ana, CA, USA) via the internal jugular or femoral vein under fluoroscopic guidance with patients in the supine position. Hemodynamic parameters included right atrial pressure (RAP), RV systolic and diastolic pressures, systolic, diastolic, and mean pulmonary artery pressures, and PAWP. All pressures were recorded at end‐expiration and averaged over three consecutive cardiac cycles. Cardiac output (CO) was determined using the direct Fick method with measured oxygen consumption when available or the indirect Fick method based on estimated oxygen consumption. Derived hemodynamic parameters were calculated as follows: Cardiac index (CI; L/min/m2): CO/body surface areaPVR (dynes·s·cm−5): 80 × (mPAP – PAWP)/CO Cardiac index (CI; L/min/m2): CO/body surface area Cardiac index (CI; L/min/m2): CO/body surface area PVR (dynes·s·cm−5): 80 × (mPAP – PAWP)/CO PVR (dynes·s·cm−5): 80 × (mPAP – PAWP)/CO Echocardiographic Assessment Comprehensive transthoracic echocardiography was performed before RHC using a commercially available ultrasound system (Vivid 7; GE Medical Systems, Milwaukee, WI) equipped with a 3.5 MHz transducer. All examinations were performed by experienced sonographers blinded to clinical and hemodynamic data. Standard parameters were measured according to American Society of Echocardiography recommendations including left atrial dimension, left ventricular (LV) end‐diastolic and end‐systolic diameters, LV ejection fraction (biplane Simpson's method), transmitral Doppler velocities (E and A waves), tissue Doppler e′ velocity, E/e′ ratio, tricuspid annular plane systolic excursion (TAPSE), tricuspid regurgitation peak gradient (TRPG), right ventricular fractional area change (RV‐FAC), and S′. Estimated systolic PAP (sPAP) was calculated as TRPG plus estimated RAP based on inferior vena cava diameter and collapsibility [27]. RV‐pulmonary artery (PA) coupling was defined as the ratio of TAPSE to sPAP (TAPSE/sPAP), a non‐invasive surrogate of RV‐PA coupling. Two‐Dimensional Speckle‐Tracking Analysis For RV strain analysis, apical four‐chamber views optimized for RV visualization were acquired at frame rates of 60–90 frames per second. Three consecutive cardiac cycles with stable image quality were stored in Digital Imaging and Communications in Medicine format and analyzed offline using dedicated software (EchoPAC; GE Medical Systems, Milwaukee, WI, USA). The RV endocardial border was manually traced at end‐diastole, and the software automatically adjusted the region of interest to accommodate wall thickness. The RV wall was divided into six segments (basal, mid, and apical portions of both the lateral free wall and the interventricular septum). Time‐strain curves were generated for each segment, and tracking quality was visually confirmed by an experienced observer blinded to clinical and hemodynamic data. Segments with inadequate tracking quality were excluded from analysis. RV mechanical dyssynchrony was quantified using the coefficient of variation of time‐to‐peak systolic strain (RV‐CV4), calculated from four mid‐basal RV segments (basal lateral, mid lateral, basal septal, and mid septal) [28]. Thus, RV‐CV4 was derived exclusively from RV segments (septal and lateral walls) and reflects intraventricular mechanical dyssynchrony within the RV. Time‐to‐peak strain was defined as the interval from the onset of the QRS complex to peak systolic strain for each segment. The coefficient of variation was calculated as the standard deviation divided by the mean (SD/mean) of the corrected time‐to‐peak strain values across the four segments. To account for heart rate variability, time‐to‐peak values were corrected by dividing by the square root of the RR interval (Bazett's formula). RV‐CV4 was calculated as the standard deviation of corrected time‐to‐peak strain divided by the mean and expressed as a percentage. All measurements were performed by a single experienced observer, and intra‐observer variability was assessed by repeating measurements in 10 randomly selected patients at least 2 weeks apart. Cardiac Magnetic Resonance Imaging CMR was performed using a 3.0‐Tesla scanner (MAGNETOM Skyra; Siemens Healthineers, Erlangen, Germany) according to standardized clinical protocols. Cine images were acquired with steady‐state free precession sequences in contiguous short‐axis slices (8 mm slice thickness, no gap) encompassing both ventricles, as well as in standard long‐axis views. RV and LV volumes and ejection fractions were analyzed by two experienced radiologists blinded to clinical and hemodynamic data using post‐processing software. Endocardial borders were manually traced at end‐diastole and end‐systole excluding trabeculations and papillary muscles from the blood pool. RV end‐diastolic volume (RVEDV), end‐systolic volume (RVESV), stroke volume (RVSV = RVEDV‐RVESV), and ejection fraction (RVEF = RVSV/RVEDV × 100%) were calculated, with corresponding LV parameters obtained in parallel. All volumes were indexed to body surface area. Interobserver reproducibility was assessed in 10 randomly selected cases. Laboratory Measurements After an overnight fast, peripheral venous blood was drawn from peripheral vein for measurements of complete blood cell counts, lipid profiles, hepatic and renal function markers, glycemic parameters, uric acid, and NT‐pro‐BNP. All biochemical analyses were performed at the clinical laboratory of Kurume University Hospital using standard automated techniques. Reference ranges were 3.6–7.0 mg/dL for men and 2.7–7.0 mg/dL for women for uric acid. For NT‐pro‐BNP, age‐specific reference values were applied: < 125 pg/mL for age < 75 years and < 450 pg/mL for age ≥ 75 years. Statistical Analysis Continuous variables are presented as mean ± standard deviation (SD) for normally distributed data or median (interquartile range) for non‐normally distributed data. Normality was assessed using the Kolmogorov‐Smirnov test. Categorical variables are presented as frequencies and percentages. We used univariate analysis to assess the correlation between RV‐CV4 and clinical, hemodynamic, imaging, and biochemical variables. Variables with p < 0.15 in univariate analysis were entered into a stepwise multiple linear regression model to identify independent predictors of RV‐CV4. Multicollinearity was evaluated using variance inflation factors with all values remaining below 5. A two‐tailed p < 0.05 was considered statistically significant. All statistical analyses were conducted using SPSS version 27.0 (IBM Corp., Armonk, NY, USA). Results Baseline Characteristics The study cohort comprised 30 patients (83% female) with a mean age of 56.9 ± 19.8 years (Table 1). The distribution of PH etiologies reflected typical referral patterns: idiopathic or heritable PAH in 8 patients (27%), connective tissue disease‐associated PAH in 8 (27%), congenital heart disease‐associated PAH in 2 (7%), PH due to lung disease in 3 (10%), chronic thromboembolic pulmonary hypertension (CTEPH) in 6 (20%), and other etiologies in 3 (10%). Mean electrocardiographic QRS duration was 94.7 ± 19.1 ms, confirming the absence of intraventricular conduction delay (QRS ≥ 120 ms) in all participants. Mean 6‐min walk distance was 396 ± 151 meters. At the time of enrollment, 21 patients (70%) were receiving PH‐specific therapy, 18 (60%) were on diuretics, and 19 (63%) were receiving anticoagulation. Table 1Patient demographics and clinical characteristics.VariablesValues (n = 30)Age, years56.9 ± 19.8Female, n (%)25 (83)Body surface area (m2)1.46 ± 0.17Cause of PH, n (%)Idiopathic/heritable PAH8 (27)CTD‐PAH8 (27)CHD‐PAH2 (7)PH due to lung disease3 (10)CTEPH6 (20)Others3 (10)HemodynamicsHeart rate, bpm71.0 ± 12.9Systolic blood pressure, mmHg120.6 ± 22.3mRAP, mmHg5.3 ± 2.9sPAP, mmHg55.7 ± 18.3dPAP, mmHg21.7 ± 7.9mPAP, mmHg34.1 ± 11.2PVR, dynes/sec/cm− 5 522.3 (289.4–692.6)Cardiac index, mL/min/m2 2.9 ± 0.86 min walk distance, m396 ± 151Medications, n (%)PH‐specific therapy21 (70)Diuretics18 (60)Anticoagulation19 (63)CMRRVEDV, mL112.4 ± 50.7RVESV, mL67.4 ± 40.2RVEF, %42.4 ± 12.0LVEDV, mL76.4 ± 26.9LVESV, mL29.7 ± 12.4LVEF, %61.2 ± 10.0QRS width, ms94.7 ± 19.1NT‐pro‐BNP, pg/mL# 142.7 (42.6–1002.5)Uric acid, mg/dL5.6 ± 1.9Uric acid > threshold†, n (%)8 (27) Note: Values are number (%), mean ± standard deviation, or #median (interquartile range).Abbreviations: CHD, congenital heart disease; CMR, cardiac magnetic resonance imaging; CTD, connective tissue disease; CTEPH, chronic thromboembolic pulmonary hypertension; dPAP, diastolic pulmonary artery pressure; LVEDV, left ventricular end‐diastolic volume; LVEF, left ventricular ejection fraction; N, number; PAH, pulmonary arterial hypertension; LVESV, left ventricular end‐systolic volume; mPAP, mean pulmonary artery pressure; mRAP, mean right atrial pressure; NT‐pro‐BNP, N‐terminal pro‐brain natriuretic peptide; PVR, pulmonary vascular resistance; RVEF, right ventricular ejection fraction; RVEDV, right ventricular end‐diastolic volume; RVESV, right ventricular end‐systolic volume; sPAP, systolic pulmonary artery pressure. † Threshold: > 6.4 mg/dL (female), > 8.9 mg/dL (male).John Wiley & Sons, Ltd. Patient demographics and clinical characteristics. Note: Values are number (%), mean ± standard deviation, or #median (interquartile range). Abbreviations: CHD, congenital heart disease; CMR, cardiac magnetic resonance imaging; CTD, connective tissue disease; CTEPH, chronic thromboembolic pulmonary hypertension; dPAP, diastolic pulmonary artery pressure; LVEDV, left ventricular end‐diastolic volume; LVEF, left ventricular ejection fraction; N, number; PAH, pulmonary arterial hypertension; LVESV, left ventricular end‐systolic volume; mPAP, mean pulmonary artery pressure; mRAP, mean right atrial pressure; NT‐pro‐BNP, N‐terminal pro‐brain natriuretic peptide; PVR, pulmonary vascular resistance; RVEF, right ventricular ejection fraction; RVEDV, right ventricular end‐diastolic volume; RVESV, right ventricular end‐systolic volume; sPAP, systolic pulmonary artery pressure. Threshold: > 6.4 mg/dL (female), > 8.9 mg/dL (male). Hemodynamic Parameters RHC demonstrated moderate‐to‐severe pulmonary hypertension with reduced cardiac output (Table 1). Systolic PAP and mPAP were 55.7 ± 18.3 mmHg and 34.1 ± 11.2 mmHg, respectively. PVR was markedly elevated at 522.3 (289.4–692.6) dyn·s·cm−5, equivalent to 6.6 ± 3.9 Wood units. Mean cardiac index was 2.9 ± 0.8 L/min/m2, indicating impaired RV performance. Mean RAP was 5.3 ± 2.9 mmHg, and mean PAWP was 8.8 ± 3.0 mmHg, confirming a pre‐capillary hemodynamic profile. Cardiac Magnetic Resonance Findings CMR demonstrated mild‐to‐moderate RV enlargement and systolic impairment (Table 1). Mean RVEDV was 112.4 ± 50.7 mL, mean RVESV was 67.4 ± 40.2 mL, and mean RVEF was reduced at 42.4 ± 12.0%. These findings were consistent with predominantly mild‐to‐moderate RV systolic dysfunction with variable degrees of remodeling in response to chronic pressure overload. In comparison, mean LVEDV was 76.4 ± 26.9 mL, mean LVESV was 29.7 ± 12.4 mL, and mean LV ejection fraction (LVEF) was 61.2 ± 10.0%, indicating preserved LV systolic function. Biomarkers NT‐pro‐BNP levels showed marked variability (142.7 [42.6–1002.5] pg/mL), reflecting heterogeneous disease severity. Mean serum uric acid was 5.6 ± 1.9 mg/dL, with 8 patients (27%) exceeding sex‐specific reference thresholds. Echocardiographic Parameters Standard echocardiographic evaluation revealed findings consistent with RV systolic impairment and elevated afterload (Table 2). Mean LVEF was preserved at 72.2 ± 6.4%, indicating normal LV systolic performance. LV diastolic function indices showed a median E/A ratio of 0.90 (0.63–1.28) and a mean E/e′ ratio of 10.4 ± 3.0, consistent with grade I diastolic dysfunction or normal diastolic function in most patients. Mean TRPG was elevated at 51.5 (38.0–74.3) mmHg, confirming the presence of PH. Indices of RV systolic function were globally impaired: median TAPSE was 15.7 (14.0–20.5) mm (reference > 17 mm), mean RV‐FAC was 32.2 ± 12.5% (reference > 35%), and mean tricuspid lateral annular systolic velocity (S′) was 9.0 (8.0–11.0) cm/s (reference > 9.5 cm/s), indicating mild‐to‐moderate RV systolic dysfunction overall. Fourteen patients (47%) had TAPSE ≤ 17 mm, and 18 (60%) had RV‐FAC ≤ 35%, indicating that a subset of patients exhibited moderate‐to‐severe impairment despite the overall cohort trend. Mean RV‐PA coupling ratio (TAPSE/sPAP) was 0.34 ± 0.16 mm/mmHg. Table 2Echocardiographic parameters of the study population.VariablesValuesLAD, mm30.9 ± 4.7LVDd, mm39.8 ± 5.7LVDs, mm23.5 ± 4.3LVEF, %72.2 ± 6.4Mitral E wave, cm/s63.1 ± 19.4Mitral A wave, cm/s69.0 ± 18.6Mitral E/A ratio# 0.90 (0.63–1.28)E/e' ratio10.4 ± 3.0TRPG, mmHg# 51.5 (38.0–74.3)TAPSE, cm# 15.7 (14.0–20.5)RV s', cm/s# 9.0 (8.0–11.0)RV‐PA coupling ratio, mm/mmHg0.34 ± 0.16RV fractional area change, %32.2 ± 12.5RV global longitudinal strain, %−17.4 ± 5.2RV free wall strain, %−19.8 ± 6.3RV free wall strain basal and mid, %−20.3 ± 7.4Time to peak systolic longitudinal strain RV basal septal0.446 ± 0.109Time to peak systolic longitudinal strain RV mid septal0.453 ± 0.093Time to peak systolic longitudinal strain RV basal lateral0.528 ± 0.134Time to peak systolic longitudinal strain RV mid lateral0.523 ± 0.129CV of the times to peak systolic strain for the mid‐basal RV segments0.134 ± 0.08 Note: Values are number (%), mean ± standard deviation, or #median (interquartile range).Abbreviations: CV, coefficient of variation; LAD, left atrial dimension; LVDd, left ventricular dimension diastole; LVDs, left ventricular dimension systole; LVEF, left ventricular ejection fraction; PA, pulmonary artery; RV, right ventricular; TAPSE, tricuspid annular plane systolic excursion; TRPG, tricuspid regurgitation peak gradient.John Wiley & Sons, Ltd. Echocardiographic parameters of the study population. Note: Values are number (%), mean ± standard deviation, or #median (interquartile range). Abbreviations: CV, coefficient of variation; LAD, left atrial dimension; LVDd, left ventricular dimension diastole; LVDs, left ventricular dimension systole; LVEF, left ventricular ejection fraction; PA, pulmonary artery; RV, right ventricular; TAPSE, tricuspid annular plane systolic excursion; TRPG, tricuspid regurgitation peak gradient. RV Strain and Mechanical Dyssynchrony Mean RV longitudinal strain across the four analyzed segments (basal‐septal, mid‐septal, basal‐lateral, and mid‐lateral) was −20.3 ± 7.4%, indicating moderate impairment of RV myocardial deformation. RV global longitudinal strain was −17.4 ± 5.2%, and RV free wall strain was −19.8 ± 6.3%. Analysis of time‐to‐peak systolic strain revealed pronounced temporal dispersion of segmental contraction. Mean heart rate‐corrected time‐to‐peak strain was significantly prolonged in the RV lateral wall (0.528 ± 0.134) compared with the septal wall (0.446 ± 0.109, p = 0.001). This pattern indicates intraventricular mechanical dyssynchrony within the RV, characterized by delayed RV free wall contraction relative to the interventricular septum. The coefficient of variation of time‐to‐peak systolic strain among the four mid‐basal segments (RV‐CV4), the primary measure of RV mechanical dyssynchrony, was 0.134 ± 0.083. Fifteen patients (50%) demonstrated RV‐CV4 values > 0.15, indicating substantial mechanical dyssynchrony. These findings suggest marked temporal heterogeneity of regional RV contraction despite the absence of electrical conduction delay. Representative time‐strain curves demonstrating mechanical dyssynchrony are shown in Figure 1. Representative time‐strain curves demonstrating right ventricular mechanical dyssynchrony. RV‐CV4 is calculated as the coefficient of variation of the times to peak‐systolic strain for the four mid‐basal RV segments. The figure shows significant temporal dispersion in peak strain timing between segments. Yellow curve: basal septal; light blue curve: mid septal; red curve: basal lateral; blue curve: mid lateral. The delayed peak strain in lateral segments (red and blue) relative to septal segments (yellow and light blue) illustrates the mechanical dyssynchrony characteristic of pressure‐overloaded right ventricles. Determinants of RV Dyssynchrony Univariate correlation analysis revealed that RV‐CV4 was significantly associated with multiple hemodynamic parameters (Table 3): sPAP (β = 0.442, p = 0.015), mPAP (β = 0.509, p = 0.004) (Figure 2), and PVR (β = 0.509, p = 0.004), and inversely with RV‐PA coupling ratio (β = −0.406, p = 0.026). Additional analysis using TRPG as an echocardiographic surrogate of pulmonary pressure showed no significant association with RV‐CV4 (β = 0.185, p = 0.329), despite its moderate correlation with invasively measured pulmonary pressures. In contrast, RV‐CV4 showed no significant correlation with cardiac index (β = −0.294, p = 0.115). Among biochemical markers, serum uric acid demonstrated a modest but significant positive correlation with RV‐CV4 (β = 0.422, p = 0.020). With regard to imaging parameters, RV‐CV4 correlated inversely with RV S′ (β = −0.363, p = 0.048), but showed no significant association with RVEDV (β = 0.254, p = 0.176) or RVEF (β = −0.240, p = 0.201), suggesting that dyssynchrony reflects contractile dysfunction rather than chamber enlargement or global systolic function. Table 3Univariate and multivariate analyses for RV dyssynchrony (RV‐CV4).VariablesUnivariate analysisMultivariate analysis β 95% CI p β 95% CI p HemodynamicssPAP0.4420.000–0.0040.015mPAP0.5090.001–0.0060.0040.5090.001–0.0060.004PVR0.5070.004–0.0170.004Cardiac index−0.294−0.070 to 0.0080.115CMR ParametersRVEDV0.2540.000–0.0010.176RVEF−0.240−0.004 to 0.0010.201Echocardiographic ParametersRV S'# −0.363−0.271 to −0.0010.048RV‐PA coupling ratio−0.406−0.385 to −0.0270.026Uric acid0.4220.003–0.0320.020 # Log‐transformed value was used. Bold p‐values indicate statistical significance.Abbreviations as in Tables 1 and 2.John Wiley & Sons, Ltd. Univariate and multivariate analyses for RV dyssynchrony (RV‐CV4). Log‐transformed value was used. Bold p‐values indicate statistical significance. Abbreviations as in Tables 1 and 2. Association between RV‐CV4 and mean pulmonary artery pressure (mPAP). RV‐CV4 shows a significant positive correlation with mPAP, indicating that increasing PAP is associated with greater mechanical dyssynchrony. To identify independent predictors of RV mechanical dyssynchrony, variables with p < 0.15 in univariate analysis (mPAP, PVR, systolic PAP, RV‐PA coupling, uric acid, and RV S′) were entered into a stepwise multiple linear regression model. Due to significant collinearity between hemodynamic variables (variance inflation factor > 5 for PVR and sPAP with mPAP) and between functional parameters (RV S′ with mPAP), these variables were excluded sequentially. In the final model, mPAP emerged as the sole independent determinant of RV‐CV4 (standardized β = 0.509, 95% CI 0.001–0.006, p = 0.004), accounting for 26% of the variance (R2 = 0.259, adjusted R2 = 0.233). These findings indicate that hemodynamic pressure overload, particularly elevated mPAP, is the principal driver of RV mechanical dyssynchrony in pre‐capillary PH patients without electrical conduction delay. Discussion Principal Findings This comprehensive multimodality study demonstrates that RV mechanical dyssynchrony in pre‐capillary PH without conduction delay is predominantly determined by hemodynamic pressure overload. mPAP emerged as the sole independent predictor of dyssynchrony, accounting for more than one quarter of its variance and highlighting the dominant role of afterload in disrupting RV contraction timing. Neither RVEDV nor RVEF remained significant after adjustment, suggesting that dyssynchrony reflects pressure‐induced heterogeneity of regional wall stress rather than the degree of structural remodeling per se. However, given the limited sample size, heterogeneity of PH etiologies, and the limited representation of patients with severe structural remodeling in our cohort, subgroup analyses were underpowered and did not yield statistically significant associations; therefore, these findings should be interpreted with caution, and definitive conclusions regarding the relative contribution of structural remodeling cannot be established. These findings provide important insights into the mechanical consequences of chronic RV pressure overload and support the concept that temporal discoordination of RV contraction represents an early manifestation of afterload‐induced dysfunction, potentially preceding overt chamber dilatation or systolic failure. Importantly, these observations were derived from a cohort characterized predominantly by mild‐to‐moderate RV systolic dysfunction, suggesting that mechanical dyssynchrony may arise prior to advanced RV failure. Taken together, our findings provide novel evidence that RV dyssynchrony in pre‐capillary PH without conduction delay is primarily determined by afterload, is dissociated from structural remodeling indices, and may be influenced by metabolic stress, thereby offering an integrated mechanistic perspective on RV dysfunction. Mechanisms of Pressure‐Induced Dyssynchrony The strong association between mPAP and RV dyssynchrony likely reflects multiple interrelated pathways. Elevated RV systolic pressure fundamentally alters ventricular geometry, particularly through leftward septal displacement and flattening, which disrupts the normal temporal sequence of regional contraction. In the presence of increased afterload, the interventricular septum, shared between both ventricles and subject to competing pressure gradients, contracts earlier than the RV free wall, creating substantial septal‐to‐lateral delay. This pattern is consistent with previous observations in PH patients and reflects altered interventricular mechanical interactions under conditions of RV pressure overload. Although septal‐lateral delay may partly RV‐ventricular interaction, our metric was confined to RV segments and therefore represents intraventricular dyssynchrony. Interventricular dyssynchrony was not assessed. Beyond geometric alterations, chronic pressure overload induces regional heterogeneity in myocardial wall stress, with higher stress concentrated in the RV free wall compared with the septum. This uneven stress distribution likely contributes to delayed contraction of the RV free wall relative to the septum, thereby promoting intraventricular mechanical dyssynchrony. It also leads to regional differences in contractile activation timing, myocardial oxygen demand, and metabolic efficiency. Furthermore, sustained pressure overload promotes adverse remodeling at the tissue level, including microvascular rarefaction, interstitial fibrosis, and cardiomyocyte hypertrophy with impaired excitation–contraction coupling. These changes likely contribute to spatially heterogeneous contraction patterns even in the absence of macroscopic electrical conduction delay, as confirmed by the normal QRS duration (< 120 ms) in all participants. The lack of association between RV dyssynchrony and cardiac index warrants particular attention. This finding suggests that RV‐CV4 primarily captures temporal mechanical discoordination rather than global pump failure, distinguishing it from conventional volumetric or ejection fraction‐ based indices. Dyssynchrony may therefore serve as a relatively early marker of RV mechanical inefficiency that precedes overt hemodynamic decompensation, potentially identifying patients who may benefit from intensified therapy before the development of advanced RV failure. Comparison With Previous Studies Previous studies have established that RV dyssynchrony is associated with disease severity and adverse outcomes in PH [18, 19, 20, 29]. Badagliacca et al. demonstrated that RV dyssynchrony in idiopathic PAH correlates with right atrial pressure and predicts clinical worsening [16, 29], whereas Murata et al. reported that dyssynchrony independently predicts mortality in PH patients [18]. However, prior studies have not systematically examined the relative contributions of hemodynamic load versus structural remodeling in determining RV dyssynchrony, particularly in populations without electrical conduction abnormalities. Our findings extend prior work by demonstrating that afterload, as reflected by mPAP, is the principal determinant of dyssynchrony independent of chamber size or systolic performance. This observation reinforces the concept that pressure overload is the dominant driver of mechanical discoordination and suggests that therapies targeting PVR may improve not only hemodynamics but also RV mechanical efficiency. Richter et al. previously demonstrated using pressure‐volume loop analysis that arterial elastance (Ea) and end‐diastolic elastance (Eed) determine RV wall stress and contribute to RV dyssynchrony [17]. Our study complements these findings by showing that mPAP obtained during routine RHC serves as a practical surrogate for afterload‐induced dyssynchrony across diverse pre‐capillary PH etiologies. Notably, the absence of independent associations between RV dyssynchrony and RV volumes or RVEF contrasts with the intuitive expectation that more advanced structural remodeling would necessarily be accompanied by greater mechanical discoordination. This dissociation suggests that dyssynchrony and chamber dilatation represent partially distinct pathophysiological processes. In our cohort, dyssynchrony appeared more closely related to hemodynamic load than to volumetric indices; however, this observation should be interpreted in the context of the limited representation of advanced structural remodeling. In our cohort, dyssynchrony appears to reflect pressure‐driven mechanical stress distribution, whereas dilatation may reflect longer‐term adaptive or maladaptive remodeling. Consequently, dyssynchrony analysis may provide complementary information to conventional volumetric assessment, particularly in patients with substantial hemodynamic burden but relatively preserved RV size. Role of Biomarkers in RV Dysfunction In univariate analysis, serum uric acid showed a modest but significant correlation with RV dyssynchrony (r = 0.422, p = 0.020), although this association did not persist in multivariate analysis. Uric acid, the terminal product of purine metabolism, serves as a surrogate marker of oxidative stress and tissue hypoxia, particularly in conditions of increased metabolic demand or impaired oxygen delivery. Elevated uric acid levels in PH have been linked to disease severity, reduced exercise capacity, and mortality, potentially reflecting xanthine oxidase activation during ischemia‐reperfusion cycles in the pressure‐overloaded RV [23, 25]. The univariate correlation observed in our study suggests that the association between uric acid and dyssynchrony is largely mediated by hemodynamic burden, as reflected by mPAP. This interpretation is consistent with the concept that elevated PAP drives both mechanical discoordination and metabolic derangement through a shared pathway of increased RV wall stress. In contrast, NT‐pro‐BNP, a well‐established marker of myocardial wall stress and volume overload, showed no significant correlation with RV dyssynchrony in our cohort. This dissociation indicates that NT‐pro‐BNP and RV dyssynchrony reflect distinct aspects of RV pathophysiology: NT‐pro‐BNP rises in response to myocyte stretch and volume overload, whereas dyssynchrony reflects temporal heterogeneity of regional contraction. The lack of correlation may also reflect the wide inter‐individual variability in NT‐pro‐BNP levels observed in our cohort (range 17–3618 pg/mL), potentially influenced by age, renal function, and comorbidities. These findings further suggest that metabolic stress markers such as uric acid may capture aspects of RV dysfunction not reflected by conventional hemodynamic or volumetric parameters. Clinical Implications The identification of mPAP as the principal determinant of RV dyssynchrony has several important clinical implications. First, it emphasizes the central importance of afterload reduction as the primary therapeutic target in PH. Current PAH‐specific therapies exert their beneficial effects primarily through reduction of PVR and PAP. Our findings suggest that these therapies may improve not only hemodynamics but also RV mechanical efficiency by restoring more coordinated contraction. Whether dyssynchrony improvement parallels hemodynamic improvement and whether such improvement translates into better clinical outcomes remain important questions for future investigation. Second, assessment of RV dyssynchrony using speckle‐tracking echocardiography may provide a noninvasive surrogate marker of hemodynamic burden. In clinical settings where serial RHC is impractical, changes in RV‐CV4 could potentially serve as a mechanistic marker of treatment response or disease progression. Third, patients exhibiting marked RV dyssynchrony despite relatively preserved RVEF may represent a high‐risk phenotype prone to future deterioration. This is particularly relevant in patients with only mild‐to‐moderate RV systolic dysfunction, in whom conventional indices may underestimate early mechanical impairment. Early identification of such patients through the strain analysis could facilitate closer monitoring, earlier therapeutic escalation, or timely referral for advanced therapies. Prospective longitudinal studies are required to determine whether changes in dyssynchrony translate into improved risk stratification or clinical outcomes. Methodological Considerations The use of RV‐CV4 derived from four mid‐basal RV segments represents a practical and reproducible approach to quantifying RV dyssynchrony. By focusing on mid‐basal segments and correcting for heart rate, this method minimizes the influence of apical trabeculations and interbeat variability. Although alternative approaches such as three‐dimensional echocardiography and cardiac magnetic resonance tissue tagging offer higher spatial resolution, they remain less accessible for routine clinical use. Two‐dimensional speckle‐tracking echocardiography therefore provides an optimal balance between technical feasibility and physiological relevance. The integration of RHC, CMR, and advanced echocardiography allowed comprehensive characterization of RV structure, function, and hemodynamics. This multimodality design strengthens the validity of our findings by linking mechanical dyssynchrony to gold‐standard invasive and volumetric assessments. Nonetheless, further standardization of acquisition protocols and analytic software will be essential to facilitate broader clinical adoption. In addition, variability in RV strain measurements, particularly in apical segments, may not solely reflect measurement noise but could represent true regional dysfunction, such as hypokinesis in advanced disease. This distinction is especially relevant in the setting of RV dilation, where altered geometry and reduced image quality may affect speckle‐tracking accuracy. Therefore, caution is warranted when interpreting segmental strain variability, as it may reflect underlying pathophysiological heterogeneity rather than mere measurement variability. The lack of association between RV dyssynchrony and TRPG may also reflect inherent limitations of echocardiographic estimation of pulmonary pressure in PH. In particular, estimation of sPAP relies on accurate assessment of RAP, which may be challenging in the absence of complete inferior vena cava data and may be further affected by severe tricuspid regurgitation. Study Limitations This study has several limitations that warrant consideration. The single‐center design and modest sample size (n = 30) may limit generalizability, particularly given the heterogeneity of pre‐capillary PH etiologies. Moreover, performing multivariable regression analysis in such a small cohort represents an important limitation; therefore, the results should be interpreted as exploratory and hypothesis‐generating rather than definitive. Although mPAP emerged as a robust determinant of RV dyssynchrony, validation in larger, multicenter cohorts across diverse disease subtypes is warranted. In addition, the cross‐sectional design precludes evaluation of temporal changes in dyssynchrony or its prognostic significance. Longitudinal studies incorporating serial hemodynamic and echocardiographic assessments are needed to determine whether dyssynchrony evolves with disease progression, responds to therapy, or predicts subsequent clinical outcomes. Treatment heterogeneity represents another potential limitation. A substantial proportion of patients were receiving PAH‐specific therapy at enrollment, which may have attenuated associations between hemodynamics, biomarkers, and RV dyssynchrony. Although assessment prior to treatment initiation would better isolate disease mechanisms, ethical considerations preclude withholding effective therapy. Notably, despite treatment, patients exhibited persistent hemodynamic impairment, suggesting incomplete normalization of pulmonary vascular load and RV mechanics. Finally, speckle‐tracking analysis is subject to measurement variability, and exclusion of segments with inadequate tracking, while necessary, may have introduced selection bias. Despite these limitations, the present study provides novel mechanistic insights into RV dyssynchrony using a clinically accessible, multimodality assessment. Conclusion In conclusion, among patients with pre‐capillary PH and preserved electrical conduction, RV mechanical dyssynchrony appears to be more closely related to pulmonary arterial pressure than to structural remodeling in this cohort. However, given the limited representation of severe remodeling, this distinction should be interpreted cautiously. The lack of independent associations with chamber volumes or systolic performance indicates that dyssynchrony constitutes a distinct manifestation of pressure‐induced mechanical dysfunction, potentially preceding overt structural decompensation. These findings emphasize the central importance of afterload reduction in optimizing RV mechanical coordination and suggest that dyssynchrony assessment using widely available speckle‐tracking echocardiography may serve as a practical, noninvasive marker of hemodynamic burden in PH. Integration of strain‐based dyssynchrony analysis into routine echocardiographic evaluation has the potential to enhance risk stratification and therapeutic monitoring in patients with pre‐capillary PH. Author Contributions All authors read and approved the final version of the manuscript. Yoshihiro Fukumoto supervised the study design and contributed to the interpretation, drafting, and revision of the manuscript. Sachiyo Igata and Nobuhiro Tahara analyzed the data, drafted the manuscript, and contributed to the manuscript revision. Atsuko Tahara, Akihiro Honda, Tadahiro Kugai, Yoshiko Eto, and Shoko Maeda‐Ogata collected the data and prepared the database. Funding The authors have nothing to report. Ethics Statement Following the Declaration of Helsinki, this study was approved by the Ethics Committee of Kurume University. Informed consent was obtained from all patients, and the data collected were kept confidential, in accordance with ethical standards. Conflicts of Interest The authors declare no conflicts of interest.